70 related articles for article (PubMed ID: 20840671)
41. No evidence for ErbB4 gene amplification in malignant melanoma.
Brockhoff G; Bock M; Gantner S; Hafner C
Acta Derm Venereol; 2011 Jun; 91(4):488-90. PubMed ID: 21547347
[No Abstract] [Full Text] [Related]
42. Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW.
Gabriëls RY; van Heijst LE; Hooghiemstra WTR; van der Waaij AM; Kats-Ugurlu G; Karrenbeld A; Robinson DJ; Tenditnaya A; Ntziachristos V; Gorpas D; Nagengast WB
J Nucl Med; 2023 May; 64(5):803-808. PubMed ID: 36604181
[TBL] [Abstract][Full Text] [Related]
43. A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Bonin S; Donada M; Bussolati G; Nardon E; Annaratone L; Pichler M; Chiaravalli AM; Capella C; Hoefler G; Stanta G
Tumour Biol; 2016 Jun; 37(6):7295-303. PubMed ID: 26666825
[TBL] [Abstract][Full Text] [Related]
44. Subcellular localization of EGFR in esophageal carcinoma cell lines.
Spohn L; Fichter C; Werner M; Lassmann S
J Cell Commun Signal; 2016 Mar; 10(1):41-7. PubMed ID: 26582583
[TBL] [Abstract][Full Text] [Related]
45. Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma.
Dahle-Smith Å; Stevenson D; Massie D; Murray GI; Dutton SJ; Roberts C; Ferry D; Osborne A; Clark C; Petty RD; Miedzybrodzka Z
Mol Cytogenet; 2015; 8():78. PubMed ID: 26478746
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.
Aichler M; Motschmann M; Jütting U; Luber B; Becker K; Ott K; Lordick F; Langer R; Feith M; Siewert JR; Walch A
Oncotarget; 2014 Aug; 5(16):6620-32. PubMed ID: 25216514
[TBL] [Abstract][Full Text] [Related]
47. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract][Full Text] [Related]
48. Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib.
Drenckhan A; Grob T; Dupree A; Dohrmann T; Mann O; Izbicki JR; Gros SJ
Langenbecks Arch Surg; 2014 Oct; 399(7):879-88. PubMed ID: 25070024
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.
Gao Z; Meng X; Mu D; Sun X; Yu J
Oncol Lett; 2014 Apr; 7(4):1118-1122. PubMed ID: 24944678
[TBL] [Abstract][Full Text] [Related]
50. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
Davison JM; Yee M; Krill-Burger JM; Lyons-Weiler MA; Kelly LA; Sciulli CM; Nason KS; Luketich JD; Michalopoulos GK; LaFramboise WA
PLoS One; 2014; 9(1):e79079. PubMed ID: 24454681
[TBL] [Abstract][Full Text] [Related]
51. High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.
Zhang Z; Xiao H; Xie F; Zhang H; Chen C; Xiao H; Yang Z; Wang D; Li Z; Wang G
BMC Cancer; 2014 Jan; 14():19. PubMed ID: 24422746
[TBL] [Abstract][Full Text] [Related]
52. MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.
Davison JM; Ellis ST; Foxwell TJ; Luketich JD; Gibson MK; Kuan SF; Nason KS
Hum Pathol; 2014 Mar; 45(3):540-8. PubMed ID: 24290360
[TBL] [Abstract][Full Text] [Related]
53. Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.
Xu Y; Sheng L; Mao W
Oncol Lett; 2013 Jan; 5(1):19-24. PubMed ID: 23255886
[TBL] [Abstract][Full Text] [Related]
54. Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma.
Yan W; Shih J; Rodriguez-Canales J; Tangrea MA; Player A; Diao L; Hu N; Goldstein AM; Wang J; Taylor PR; Lippman SM; Wistuba II; Emmert-Buck MR; Erickson HS
Am J Pathol; 2013 Feb; 182(2):529-39. PubMed ID: 23219752
[TBL] [Abstract][Full Text] [Related]
55. [Update on Barrett esophagus and Barrett carcinoma].
Werner M; Laßmann S
Pathologe; 2012 Nov; 33 Suppl 2():253-7. PubMed ID: 23011020
[TBL] [Abstract][Full Text] [Related]
56. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
Marx AH; Zielinski M; Kowitz CM; Dancau AM; Thieltges S; Simon R; Choschzick M; Yekebas E; Kaifi JT; Mirlacher M; Atanackovic D; Brümmendorf TH; Fiedler W; Bokemeyer C; Izbicki JR; Sauter G
Histopathology; 2010 Sep; 57(3):418-26. PubMed ID: 20840671
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
58. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
59. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
Ooi A; Zen Y; Ninomiya I; Tajiri R; Suzuki S; Kobayashi H; Imoto I; Dobashi Y
Pathol Int; 2010 Jun; 60(6):466-71. PubMed ID: 20518902
[TBL] [Abstract][Full Text] [Related]
60. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
